The PAK4 kinase in cell growth and transformation

Project Details

Description

[unreadable] DESCRIPTION (provided by applicant): The goal of the proposed experiments is to determine how the serine/threonine kinase Pak4 functions in the regulation of cell growth and transformation. Pak4 is an effector of the Rho GTPases Cdc42 and Rac, and was originally identified as a protein that functions in cytoskeletal organization. More recently, Pak4 was also shown to have important roles in controlling cell growth and survival. Pak4 is overexpressed in cancer cell lines, and Pak4 is highly transforming in established immortalized cell lines. In contrast, in primary cells Pak4 has a completely different function and triggers premature senescence rather than increased growth. In both respects Pak4 is similar to strong oncogenes such as oncogenic Ras, which are highly transforming in immortalized cells but inhibit growth in primary cells. Studying the role for Pak4 in cell growth is very important for understanding how Pak4 and Rho GTPases are associated with oncogenic transformation. The experiments in this proposal will take advantage of Pak4 null fibroblasts that have been generated in our lab, in order to study Pak4's role in the regulation of cell growth and transformation in immortalized cells, and premature senescence in primary cells. The following aims will be addressed: Aim 1.1. What role does Pak4 have in oncogenic transformation? Immortalized Pak4 null and control fibroblasts will be used to test the hypothesis that Pak4 is essential for transformation by Rho GTPases and their activators. We will also study the signaling pathways involved in Pak4 mediated transformation. Aim 1.2. What role does Pak4 have in the control of cell proliferation? The control of cell proliferation and transformation are closely associated. Here we will use the immortalized Pak4 null fibroblasts to test the hypothesis that Pak4 is required for cell cycle entry and proliferation in response to Rho GTPases. We will also determine whether cell cycle regulatory proteins function downstream to Pak4 during cell cycle progression. Aim 2. What signaling pathways mediate Pak4 induced premature senescence in primary cells? We will first test the hypothesis that Pak4 induced senescence in primary ceils is mediated by the ERK MAP Kinase, leading to induction of cell cycle regulatory proteins and subsequent inhibition of cell growth. We will also test the hypothesis that cytoskeletal regulatory proteins play an important role in Pak4 induced senescence. Finally, we will also determine whether Pak4 is required for oncogene induced senescence. [unreadable] [unreadable]
StatusFinished
Effective start/end date8/1/985/31/10

Funding

  • National Cancer Institute: $250,691.00
  • National Cancer Institute: $280,903.00
  • National Cancer Institute: $258,209.00
  • National Cancer Institute: $326,025.00
  • National Cancer Institute: $296,571.00
  • National Cancer Institute: $243,387.00
  • National Cancer Institute: $81,750.00
  • National Cancer Institute: $296,651.00
  • National Cancer Institute: $304,521.00
  • National Cancer Institute: $45,122.00

ASJC

  • Cell Biology

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.